搜索临床试验以:Bioavailability Pharmacokinetic Formulation
总计16168个结果
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center完全的
-
University Hospital, Geneva主动,不招人
-
Acerta Pharma BV完全的
-
Agios Pharmaceuticals, Inc.完全的
-
Orion Corporation, Orion PharmaEndo Pharmaceuticals完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V.完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Otsuka Pharmaceutical Co., Ltd.完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Merck Sharp & Dohme LLC完全的人类免疫缺陷病毒 1 (HIV-1)